UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 77

Sortiert nach

Klotho Protects Dopaminergic Neuron Oxidant-Induced Degeneration by Modulating ASK1 and p38 MAPK Signaling Pathways

PloS one, 2015-10, Vol.10 (10), p.e0139914

2015

Link zum Volltext

Verfügbarkeit prüfen

Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation

Progress in neurobiology, 2007-12, Vol.83 (5), p.310-331

2007

Link zum Volltext

Verfügbarkeit prüfen

The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: Clinical relevance

Experimental neurology, 2010-02, Vol.221 (2), p.329-334

2010

Link zum Volltext

Verfügbarkeit prüfen

Coordinated role of voltage-gated sodium channels and the Na+/H+ exchanger in sustaining microglial activation during inflammation

Toxicology and applied pharmacology, 2013-12, Vol.273 (2), p.355-364

2013

Link zum Volltext

Verfügbarkeit prüfen

Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation

PloS one, 2012-01, Vol.7 (1), p.e29935

2012

Link zum Volltext

Verfügbarkeit prüfen

Neuroprotective and Anti-inflammatory Properties of a Coffee Component in the MPTP Model of Parkinson’s Disease

Neurotherapeutics, 2013, Vol.10 (1), p.143-153

2013

Link zum Volltext

Verfügbarkeit prüfen

Animal models of Parkinson’s disease progression

Acta neuropathologica, 2008-04, Vol.115 (4), p.385-398

2008

Link zum Volltext

Verfügbarkeit prüfen

Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment

Journal of neurochemistry, 2001-10, Vol.79 (1), p.152-160

2001

Link zum Volltext

Verfügbarkeit prüfen

Adenosinergic Protection of Dopaminergic and GABAergic Neurons against Mitochondrial Inhibition through Receptors Located in the Substantia Nigra and Striatum, Respectively

The Journal of neuroscience, 2003-11, Vol.23 (34), p.10982-10987

2003

Link zum Volltext

Verfügbarkeit prüfen

Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model

The Journal of neuroscience, 2011-05, Vol.31 (19), p.6963-6971

2011

Link zum Volltext

Verfügbarkeit prüfen

8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism

The Journal of biological chemistry, 2002-09, Vol.277 (39), p.36040-36044

2002

Link zum Volltext

Verfügbarkeit prüfen

Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior

Human molecular genetics, 2015-10, Vol.24 (20), p.5805-5827

2015

Link zum Volltext

Verfügbarkeit prüfen

The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism

Experimental neurology, 2013-12, Vol.250, p.376-383

2013

Link zum Volltext

Verfügbarkeit prüfen

Mitochondrial stress-induced dopamine efflux and neuronal damage by malonate involves the dopamine transporter

The Journal of pharmacology and experimental therapeutics, 2007-02, Vol.320 (2), p.747

2007

Link zum Volltext

Verfügbarkeit prüfen

Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson's disease

Parkinsonism & related disorders, 2008-01, Vol.14 (Suppl 2), p.S116-S118

2008

Link zum Volltext

Verfügbarkeit prüfen

Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease

Experimental neurology, 2012-04, Vol.234 (2), p.482-487

2012

Link zum Volltext

Verfügbarkeit prüfen

Role for Excitatory Amino Acids in Methamphetamine-Induced Nigrostriatal Dopaminergic Toxicity

Science (American Association for the Advancement of Science), 1989-01, Vol.243 (4889), p.398-400

1989

Link zum Volltext

Verfügbarkeit prüfen

Na⁺/H⁺ exchanger inhibition modifies dopamine neurotransmission during normal and metabolic stress conditions

Journal of neurochemistry, 2008-07, Vol.106 (1), p.231-243

2008

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata

The Journal of pharmacology and experimental therapeutics, 2000-05, Vol.293 (2), p.336

2000

Link zum Volltext

Verfügbarkeit prüfen

Treatment of mice with methamphetamine produces cell loss in the substantia nigra

Brain research, 1996-10, Vol.738 (1), p.172-175

1996

Link zum Volltext

Verfügbarkeit prüfen

Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake

The Journal of pharmacology and experimental therapeutics, 1997-03, Vol.280 (3), p.1432

1997

Link zum Volltext

Verfügbarkeit prüfen

In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium

The Journal of pharmacology and experimental therapeutics, 2000-05, Vol.293 (2), p.329

2000

Link zum Volltext

Verfügbarkeit prüfen

Analysis of VMAT2 Binding After Methamphetamine or MPTP Treatment

Journal of neurochemistry, 2000-05, Vol.74 (5), p.2217-2220

2000

Link zum Volltext

Verfügbarkeit prüfen

Dopamine depletion causes fragmented clustering of neurons in the sensorimotor striatum: Evidence of lasting reorganization of corticostriatal input

Journal of comparative neurology (1911), 2002-10, Vol.452 (1), p.24-37

2002

Link zum Volltext

Verfügbarkeit prüfen

Protection of Malonate-Induced GABA But Not Dopamine Loss by GABA Transporter Blockade in Rat Striatum

Experimental neurology, 2002-07, Vol.176 (1), p.193-202

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(76)
Buchkapitel
(1)

Sprache

Englisch
(77)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Animals
(51)
Science & Technology
(49)
Life Sciences & Biomedicine
(45)
Mice
(40)
Male
(36)
Neurosciences & Neurology
(34)
Neurosciences
(31)
Biological And Medical Sciences
(30)
Dopamine - Metabolism
(25)
Medical Sciences
(23)
Corpus Striatum - Drug Effects
(19)
Mptp
(19)
Rats
(18)
Neurology
(16)
1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine
(15)
Corpus Striatum - Metabolism
(15)
Dopamine
(14)
Substantia Nigra - Drug Effects
(14)
Pharmacology & Pharmacy
(13)
Methamphetamine
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Klotho Protects Dopaminergic Neuron Oxidant-Induced Degeneration by Modulating ASK1 and p38 MAPK Signaling Pathways

Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation

The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: Clinical relevance

Coordinated role of voltage-gated sodium channels and the Na+/H+ exchanger in sustaining microglial activation during inflammation

Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation

Neuroprotective and Anti-inflammatory Properties of a Coffee Component in the MPTP Model of Parkinson’s Disease

Animal models of Parkinson’s disease progression

Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment

Adenosinergic Protection of Dopaminergic and GABAergic Neurons against Mitochondrial Inhibition through Receptors Located in the Substantia Nigra and Striatum, Respectively

Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model

8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism

Engrailed-2 (En2) deletion produces multiple neurodevelopmental defects in monoamine systems, forebrain structures and neurogenesis and behavior

The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism

Mitochondrial stress-induced dopamine efflux and neuronal damage by malonate involves the dopamine transporter

Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson's disease

Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease

Role for Excitatory Amino Acids in Methamphetamine-Induced Nigrostriatal Dopaminergic Toxicity

Na⁺/H⁺ exchanger inhibition modifies dopamine neurotransmission during normal and metabolic stress conditions

Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata

Treatment of mice with methamphetamine produces cell loss in the substantia nigra

Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake

In vitro studies of striatal vesicles containing the vesicular monoamine transporter (VMAT2): rat versus mouse differences in sequestration of 1-methyl-4-phenylpyridinium

Analysis of VMAT2 Binding After Methamphetamine or MPTP Treatment

Dopamine depletion causes fragmented clustering of neurons in the sensorimotor striatum: Evidence of lasting reorganization of corticostriatal input

Protection of Malonate-Induced GABA But Not Dopamine Loss by GABA Transporter Blockade in Rat Striatum

Suchergebnisse filtern